Anticancer Therapies – Products
Product News
PRECOS Enjoys Successful First Year with Significant Client Growth
Senior scientific expert appointed to support increasing demand.
Product News
Polyplus-transfection Announces the Appointment of Ten Additional Biologists and Chemists to Support Multiple Pre-clinical Studies
Polyplus-transfection celebrates ten years of commercial growth and research and development in the field of transfection bio-tools and therapeutics with further additions to team.
Product News
Critical Outcome Technologies Inc. Announces Definitive Proof of COTI-2’s Target and Single
COTI-2 is the first drug developed using the Company’s proprietary artificial intelligence system, CHEMSAS®.
Product News
PRECOS Partners with Reliable Cancer Therapies to Provide Rigorous Scientific Evidence for Complementary Cancer Medicines
PRECOS provide drug efficacy work to support RCT's research on complementary medicines.
Product News
Endomagnetics Secures Funding for Expansion and Product Launch
Technology will extend the availability of best practice in cancer staging globally.
Product News
Adaptimmune Announces Opening of Pilot Clinical Trial in Synovial Sarcoma
Personalized therapy is targeted to patients who have failed initial treatment.
Product News
Metanomics Health Launches its Energy Metabolite Platform - a Unique Target Platform Based on Metabolite Profiling
The targeted platform maps key metabolites affecting the energy status of a biological system.
Product News
Plasticell‘s CombiCult™ v2.0 Platform Wins International R&D 100 Award
Plasticell’s high throughput screen for stem cell differentiation joins list of the most significant technology products developed globally in the last 49 years.
Product News
FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
DPX-Survivac will be tested in patients with ovarian cancer.
Product News
OGT to Develop Tumour Profiling Assay to Facilitate Personalized Cancer Treatment
Company receives £1.16m award from the UK’s Technology Strategy Board.
Advertisement
